| Assigned Number |
Title |
Version Date | Publication Type | Other Location | Language |
|---|---|---|---|---|---|
| F-02505 | Effective for use on and after 07/01/2019: Prior Authorization Drug Attachment for Lipotropics, Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors | July 1, 2019 |
Word
|
None | English |
| F-02505 | Effective for use on and after 07/01/2019: Prior Authorization Drug Attachment for Lipotropics, Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors | July 1, 2019 |
PDF
|
None | English |
| F-02505 | Effective for use on and after 07/01/2019: Prior Authorization Drug Attachment for Lipotropics, Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors Instructions | July 1, 2019 |
PDF
|
None | English |
Last Revised: July 23, 2019
